financetom
Business
financetom
/
Business
/
AMC Entertainment Stock Is Tumbling Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AMC Entertainment Stock Is Tumbling Monday: What's Going On?
Aug 5, 2024 6:35 AM

AMC Entertainment Holdings Inc ( AMC ) shares are trading lower Monday following the company’s second-quarter financial results. Here’s what you need to know.

What To Know: After the market close on Friday, AMC reported second-quarter revenue of $1.03 billion, in line with analyst estimates, according to Benzinga Pro. The company also reported a second-quarter adjusted loss of 43 cents per share.

Adjusted EBITDA came in at $29.4 million in the quarter. The company noted that it achieved its highest adjusted EBITDA in company history in June. AMC ended the quarter with $770.3 million in cash and cash equivalents.

"As expected, the second quarter started slowly with the box office adversely impacted by the 2023 Hollywood writers and actors strikes. However, the quarter finished with incredible strength powered by the success of Disney's INSIDE OUT 2, which is now the highest grossing animated movie of all time. AMC saw a remarkable contrast between the early quarter with a dearth of movie releases and the end of the quarter with a record setting movie delighting audiences in our theatres,” said Adam Aron, chairman and CEO of AMC.

See Also: Nasdaq, R2K Futures Tumble Over 4%, VIX Spikes Over 100%, Bitcoin Plunges Hard As Global Sell-Off Deepens Amid Recession Fears

Why It Matters: Aron stressed that AMC operated as if it were “two different companies” in the beginning of the quarter versus the end of the quarter. The strong adjusted EBITDA momentum from June continued into July, Aron said.

"With a long list of blockbuster movie titles opening in theatres during the remainder of the year and into 2025 and 2026, the industry-wide box office now appears to us to be poised for sustained growth. Looking ahead, we believe that bodes ever so well for the increasing cash generation potential from AMC's movie theatres both at home and abroad,” Aron said.

AMC noted that it completed several financing transactions during the quarter that took up $2.45 billion of its debt, extending maturities to 2029 and 2030. The company said the stage is now set for “continued recovery” at AMC.

Following the print, Wedbush analyst Alicia Reese reiterated AMC with a Neutral rating and maintained a price target of $4.

AMC Price Action: AMC shares were down 14% at $4.25 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Miata Metals Closes the $7.1-Million Purchase of 79North, Establishes Gold Exploration Portfolio in Suriname
Miata Metals Closes the $7.1-Million Purchase of 79North, Establishes Gold Exploration Portfolio in Suriname
Oct 17, 2024
11:09 AM EDT, 10/17/2024 (MT Newswires) -- Miata Metals ( MMETF ) on Thursday said it closed its acquisition of 79North in a $7.1 million all-share transaction. Miata now holds a 70% interest in the Sela Creek Gold Project, which it can increase to 100%, and a 70% interest in the Nassau gold project, both in Suriname. Miata is in...
Update: Iridium Communications Shares Rise After Company Swings to Q3 Net Income
Update: Iridium Communications Shares Rise After Company Swings to Q3 Net Income
Oct 17, 2024
11:08 AM EDT, 10/17/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.) Iridium Communications ( IRDM ) shares were up nearly 16% in recent Thursday trading after the company reported Q3 net income of $0.21 per diluted share, swinging from a loss of $0.01 a year earlier. Analysts polled by Capital IQ...
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
Oct 17, 2024
On Thursday, Amicus Therapeutics ( FOLD ) announced that it has entered into a License Agreement with Teva Pharmaceuticals Inc. . The agreement resolves the patent litigation brought by Amicus in response to Teva’s Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of Galafold (migalastat) 123mg capsules before the expiration of the applicable patents. Also Read: Teva...
Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal
Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal
Oct 17, 2024
11:12 AM EDT, 10/17/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.) Amicus Therapeutics' ( FOLD ) shares were up over 12% in recent trading Thursday after the company said it agreed to settle its patent litigation against Teva Pharmaceuticals (TEVA). Amicus said it agreed to grant Teva a license to market its generic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved